Who owns cabaletta bio?

Cabaletta Bio's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (4.98%), Perceptive Advisors LLC (4.67%), Commodore Capital LP (4.43%), Jennison Associates LLC (3.80%), Wellington Management Group LLP (1.26%) and Price T Rowe Associates Inc. MD (1.23%).

Should you buy cabaletta bio (Caba) stock?

There are currently 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CABA shares. View CABA analyst ratings or view top-rated stocks. What is Cabaletta Bio's stock price target for 2024? 11 brokers have issued twelve-month target prices for Cabaletta Bio's shares.

What are the target prices for cabaletta bio's shares?

11 brokers have issued twelve-month target prices for Cabaletta Bio's shares. Their CABA share price targets range from $10.00 to $50.00. On average, they expect the company's stock price to reach $29.27 in the next twelve months. This suggests a possible upside of 29.2% from the stock's current price.